Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Destinasi Tirta Nusantara Tbk (PDES) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs Destinasi Tirta Nusantara Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Destinasi Tirta Nusantara Tbk trades at Rp406 (market cap 290.29B, 1.5K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. and Destinasi Tirta Nusantara Tbk are close in size by market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 1.5K). Which is the better fit depends on your goals.
| DGNS | PDES | |
|---|---|---|
Market Cap | 310.75B | 290.29B |
Volume | 963.6K | 1.5K |
Lot | 9.64K | 15 |
Turnover | 217.67M | 607.8K |
Average Price | 225.89 | 405.2 |
Value | 217.67M | 607.8K |
Indicative Equilibrium Price | 226 | — |
Indicative Equilibrium Volume | 1K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →About Destinasi Tirta Nusantara Tbk
PT Destinasi Tirta Nusantara Tbk (the company) was established on 30 Oct 1999 based on Notaries Deed No. 36 and the deed of establishment was approved by the the Ministry of Justice dated Feb 23, 2000. The Company’s articles of association has been amended several times, most recently by notarial deed No. 187 and No.136 of Wijanto Suwongso, S.H., dated Jun 28, 2007 and 24 Oct 07, concerning among others, increase authorized, Paid up Capital, par value and public offering.
Read more on PDES →
